235 related articles for article (PubMed ID: 32004348)
1. Evaluation of the CareStart™ glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in the field settings and assessment of perceived risk from primaquine at the community level in Cambodia.
Wojnarski B; Lon C; Sea D; Sok S; Sriwichai S; Chann S; Hom S; Boonchan T; Ly S; Sok C; Nou S; Oung P; Kong N; Pheap V; Thay K; Dao V; Kuntawunginn W; Feldman M; Gosi P; Buathong N; Ittiverakul M; Uthaimongkol N; Huy R; Spring M; Lek D; Smith P; Fukuda MM; Wojnarski M
PLoS One; 2020; 15(1):e0228207. PubMed ID: 32004348
[TBL] [Abstract][Full Text] [Related]
2. Field trial evaluation of the performances of point-of-care tests for screening G6PD deficiency in Cambodia.
Roca-Feltrer A; Khim N; Kim S; Chy S; Canier L; Kerleguer A; Tor P; Chuor CM; Kheng S; Siv S; Kachur PS; Taylor WR; Hwang J; Menard D
PLoS One; 2014; 9(12):e116143. PubMed ID: 25541721
[TBL] [Abstract][Full Text] [Related]
3. Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency.
Kheng S; Muth S; Taylor WR; Tops N; Kosal K; Sothea K; Souy P; Kim S; Char CM; Vanna C; Ly P; Ringwald P; Khieu V; Kerleguer A; Tor P; Baird JK; Bjorge S; Menard D; Christophel E
BMC Med; 2015 Aug; 13():203. PubMed ID: 26303162
[TBL] [Abstract][Full Text] [Related]
4. Glucose 6 Phosphate Dehydrogenase (G6PD) quantitation using biosensors at the point of first contact: a mixed method study in Cambodia.
Adhikari B; Tripura R; Dysoley L; Callery JJ; Peto TJ; Heng C; Vanda T; Simvieng O; Cassidy-Seyoum S; Ley B; Thriemer K; Dondorp AM; von Seidlein L
Malar J; 2022 Oct; 21(1):282. PubMed ID: 36195916
[TBL] [Abstract][Full Text] [Related]
5. Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda.
Roh ME; Oyet C; Orikiriza P; Wade M; Mwanga-Amumpaire J; Boum Y; Kiwanuka GN; Parikh S
Am J Trop Med Hyg; 2016 Nov; 95(5):1094-1099. PubMed ID: 27672207
[TBL] [Abstract][Full Text] [Related]
6. G6PD testing and radical cure for Plasmodium vivax in Cambodia: A mixed methods implementation study.
Kheang ST; Ridley R; Ngeth E; Ir P; Ngor P; Sovannaroth S; Lek D; Phon S; Kak N; Yeung S
PLoS One; 2022; 17(10):e0275822. PubMed ID: 36264996
[TBL] [Abstract][Full Text] [Related]
7. Glucose-6-phosphate dehydrogenase deficiency among Yemeni children residing in malaria-endemic areas of Hodeidah governorate and evaluation of a rapid diagnostic test for its detection.
Abdul-Ghani R; Mahdy MA; Saif-Ali R; Alkubati SA; Alqubaty AR; Al-Mikhlafy AA; Al-Eryani SM; Al-Mekhlafi AM; Alhaj A
Malar J; 2016 Jun; 15():327. PubMed ID: 27329471
[TBL] [Abstract][Full Text] [Related]
8. Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.
Kim S; Nguon C; Guillard B; Duong S; Chy S; Sum S; Nhem S; Bouchier C; Tichit M; Christophel E; Taylor WR; Baird JK; Menard D
PLoS One; 2011; 6(12):e28357. PubMed ID: 22164279
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
Taylor WRJ; Kim S; Kheng S; Muth S; Tor P; Christophel E; Mukaka M; Kerleguer A; Luzzatto L; Baird JK; Menard D
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009690. PubMed ID: 34495956
[TBL] [Abstract][Full Text] [Related]
10. Performance of the Access Bio/CareStart rapid diagnostic test for the detection of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis.
Ley B; Winasti Satyagraha A; Rahmat H; von Fricken ME; Douglas NM; Pfeffer DA; Espino F; von Seidlein L; Henriques G; Oo NN; Menard D; Parikh S; Bancone G; Karahalios A; Price RN
PLoS Med; 2019 Dec; 16(12):e1002992. PubMed ID: 31834890
[TBL] [Abstract][Full Text] [Related]
11. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon.
Peixoto HM; Brito MA; Romero GA; Monteiro WM; de Lacerda MV; de Oliveira MR
Malar J; 2016 Feb; 15():82. PubMed ID: 26864333
[TBL] [Abstract][Full Text] [Related]
13. Barriers to routine G6PD testing prior to treatment with primaquine.
Ley B; Thriemer K; Jaswal J; Poirot E; Alam MS; Phru CS; Khan WA; Dysoley L; Qi G; Kheong CC; Shamsudin UK; Chen I; Hwang J; Gosling R; Price RN
Malar J; 2017 Aug; 16(1):329. PubMed ID: 28797255
[TBL] [Abstract][Full Text] [Related]
14. Comparison of glucose-6 phosphate dehydrogenase status by fluorescent spot test and rapid diagnostic test in Lao PDR and Cambodia.
Henriques G; Phommasone K; Tripura R; Peto TJ; Raut S; Snethlage C; Sambo I; Sanann N; Nguon C; Adhikari B; Pongvongsa T; Imwong M; von Seidlein L; Day NP; White NJ; Dondorp AM; Newton P; Ley B; Mayxay M
Malar J; 2018 Jun; 17(1):243. PubMed ID: 29929514
[TBL] [Abstract][Full Text] [Related]
15. Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
Devine A; Parmiter M; Chu CS; Bancone G; Nosten F; Price RN; Lubell Y; Yeung S
PLoS Negl Trop Dis; 2017 May; 11(5):e0005602. PubMed ID: 28542194
[TBL] [Abstract][Full Text] [Related]
16. The challenges of introducing routine G6PD testing into radical cure: a workshop report.
Ley B; Luter N; Espino FE; Devine A; Kalnoky M; Lubell Y; Thriemer K; Baird JK; Poirot E; Conan N; Kheong CC; Dysoley L; Khan WA; Dion-Berboso AG; Bancone G; Hwang J; Kumar R; Price RN; von Seidlein L; Domingo GJ
Malar J; 2015 Sep; 14():377. PubMed ID: 26416229
[TBL] [Abstract][Full Text] [Related]
17. G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients.
Avalos S; Mejia RE; Banegas E; Salinas C; Gutierrez L; Fajardo M; Galo S; Pinto A; Mejia A; Fontecha G
Malar J; 2018 Nov; 17(1):415. PubMed ID: 30409136
[TBL] [Abstract][Full Text] [Related]
18. Glucose-6-phosphate dehydrogenase deficiency prevalence and genetic variants in malaria endemic areas of Colombia.
Valencia SH; Ocampo ID; Arce-Plata MI; Recht J; Arévalo-Herrera M
Malar J; 2016 May; 15(1):291. PubMed ID: 27225440
[TBL] [Abstract][Full Text] [Related]
19. Radical cure for Plasmodium vivax malaria after G6PD qualitative testing in four provinces in Cambodia, results from Phase I implementation.
Lek D; Tsai YC; Hirano J; Sovannaroth S; Bunreth V; Vonn P; Vannthen O; Bunkea T; Samphornarann T; Sokomar N; Sarath M; Kheang ST; Wong E; Burbach MK; Hughes J; Rekol H
Malar J; 2024 Feb; 23(1):56. PubMed ID: 38395925
[TBL] [Abstract][Full Text] [Related]
20. Glucose-6-Phosphate Dehydrogenase (G6PD) Measurement Using Biosensors by Community-Based Village Malaria Workers and Hospital Laboratory Staff in Cambodia: A Quantitative Study.
Adhikari B; Tripura R; Dysoley L; Peto TJ; Callery JJ; Heng C; Vanda T; Simvieng O; Cassidy-Seyoum S; Thriemer K; Dondorp AM; Ley B; Seidlein LV
Pathogens; 2023 Mar; 12(3):. PubMed ID: 36986323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
